Rare diseases
Investigational molecules
Locations
Via Dei Lavoratori 54, 20092 Cinisello Balsamo, Italy
Italfarmaco S.p.A. supports clinical research in polycythemia vera and broader chronic myeloproliferative neoplasms, with particular attention to JAK2V617F-positive disease. The funded studies focus on treatment activity and longer-term clinical management in this blood cancer setting.
These programs reflect sustained interest in therapies for myeloproliferative disorders and related hematology indications.
Italfarmaco S.p.A. runs clinical trials in conditions such as Duchenne muscular dystrophy, Polycythaemia vera, Contraception, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgium
AustriaBelgiumItalyItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
